Terkko Navigator / -/ Feeds / " ( ( Spondyliitti )|( Selkänikamatulehdus )|( Selkänikaman tulehdus )|( Nikaman tulehdus"

Highlights from the literature

Patient-reported adherence to physical exercises of patients with ankylosing spondylitis

Ankyloserande spondylit: behandling med biologiska mediciner; en registerstudie

Long-term Safety of Secukinumab Over Five Years in Patients with Moderate-to-severe Plaque Psoriasis, Psoriatic Arthritis and Ankylosing Spondylitis: Update on Integrated Pooled Clinical Trial and Post-marketing Surveillance Data

Lessons learned from a pilot implementation of physical activity recommendations in axial spondyloarthritis exercise group therapy

Secukinumab, an Interleukin-17A Inhibitor, in Ankylosing Spondylitis

Healthcare, Vol. 10, Pages 132: Effectiveness of Physiotherapy in Patients with Ankylosing Spondylitis: A Systematic Review and Meta-Analysis

DNA methylation and transcription of the FOXO3a gene are associated with ankylosing spondylitis

STAT3 and SPI1, may lead to the immune system dysregulation and heterotopic ossification in ankylosing spondylitis

Unidirectional porous beta-tricalcium phosphate as a potential bone regeneration material for infectious bony cavity without debridement in pyogenic spondylitis

Spinal deformity correction in ankylosing spondylitis

Clinical experience with the European Ankylosing Spondylitis Infliximab Cohort (EASIC): long-term extension over 7 years with focus on clinical efficacy and safety

Survival of disease-modifying antirheumatic drugs used as the first antirheumatic medication in the treatment of ankylosing spondylitis in Finland. A nationwide population-based register study

Prediction of Vertebral Fractures by Trabecular Bone Score in Patients With Ankylosing Spondylitis

Identification of multiple risk variants for ankylosing spondylitis through high-density genotyping of immune-related loci.

Epistatic interactions between killer immunoglobulin-like receptors and human leukocyte antigen ligands are associated with ankylosing spondylitis

Spondylitis-psoriasis-enthesitis-enterocolitis-dactylitis-uveitis-peripheral synovitis (SPEED-UP) treatment.

Benefit of Biological Drugs for Quality of Life in Patients with Ankylosing Spondylitis: A Systematic Review and Meta-Analysis of Clinical Trials.

Candida Spondylitis Considered as Microbial Substitution After Multiple Surgeries for Postoperative Lumbar Spine Infection

Ankylosing Spondylitis and the Risk of Hip Fractures: a Matched Cohort Study

Might axial myofascial properties and biomechanical mechanisms be relevant to ankylosing spondylitis and axial spondyloarthritis?

Etanercept in the Longterm Treatment of Patients With Ankylosing Spondylitis.

Genome-wide association study of ankylosing spondylitis identifies non-MHC susceptibility loci.

Interaction between ERAP1 and HLA-B27 in ankylosing spondylitis implicates peptide handling in the mechanism for HLA-B27 in disease susceptibility.

JCM, Vol. 9, Pages 2696: Effectiveness of Global Postural Reeducation in Ankylosing Spondylitis: A Systematic Review and Meta-Analysis

Effectiveness of Global Postural Reeducation in Ankylosing Spondylitis: A Systematic Review and Meta-Analysis.

Coincident remission of ankylosing spondylitis after autologous stem cell transplantation for multiple myeloma

Safety and Efficacy of Intravenous Golimumab in Adults with Ankylosing Spondylitis: Results through 1 Year of the GO-ALIVE Study.

Quality of internet videos related to exercise therapy of ankylosing spondylitis from mainland China

An infected aneurysm of the vertebral artery following cervical pyogenic spondylitis: a case report and literature review

JCM, Vol. 10, Pages 5345: Risk Factors of Coexisting Septic Spondylitis and Arthritis: A Case-Control Study in a Tertiary Referral Hospital

Ankylosing spondylitis: current approaches to treatment.

Magnetic Resonance Imaging Assessment of Spinal Inflammation in Patients Treated for Ankylosing Spondylitis.

Ankylosing spondylitis: current approaches to treatment.

Ankylosing Spondylitis and Spinal Cord Injury.

Sustained efficacy and safety, including patient-reported outcomes, with etanercept treatment over 5 years in patients with ankylosing spondylitis.

The European Ankylosing Spondylitis Infliximab Cohort (EASIC): a European multicentre study of long term outcomes in patients with ankylosing spondylitis treated with infliximab.

Secukinumab, an Interleukin-17A Inhibitor, in Ankylosing Spondylitis.

Biological treatment in ankylosing spondylitis in the Nordic countries during 2010-2016: a collaboration between five biological registries.

Case report: Candida krusei spondylitis in an immunocompromised patient

Potential regulatory factors in the pathogenesis of ankylosing spondylitis.

Total spinal involvement due to delayed diagnosis and treatment of noncontiguous brucellar spondylitis

Clinical expression, but not disease outcome, may vary according to age at disease onset in psoriatic spondylitis.

Aspergillus spondylitis: case series and literature review

Tumour necrosis factor inhibitors slow radiographic progression in patients with ankylosing spondylitis: 18-year real-world evidence

Gait characteristics in patients with ankylosing spondylitis: a systematic review.

Validation of the Ankylosing Spondylitis Quality of Life assessment tool in patients with non-radiographic axial spondyloarthritis.

Autoantibodies against Protein Phosphatase Magnesium-Dependent 1A as a Biomarker for Predicting Radiographic Progression in Ankylosing Spondylitis Treated with Anti-Tumor Necrosis Factor Agents.

Prevalence of low bone mineral density in ankylosing spondylitis, correlation with disease activity, and serum sclerostin levels